Fahad Khaliq/X
Jan 7, 2026, 08:50
Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
Fahad Khaliq, Doctor of Medicine at Allied Hospital, Faisalabad, reposted from Muhammad Moor on X:
”Faster, potent, better, reversible, better mortality results
But here’s the plot twist!
If a patient is already on anticoagulation/high risk bleed, Clopidogrel is preferred
Rule of thumb:
• STEMI pt undergoing PCI: Ticagrelor
• STEMI pt undergoing Thrombolysis: Clopidogrel”
Quoting Muhammad Moor‘s post:
”Why is Ticagrelor sometimes preferred over other antiplatelets in acute coronary syndrome (ACS)?”

Stay updated with Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health